F-STAR THERAPEUTICS INC (FSTX) Stock News

USA - Nasdaq - NASDAQ:FSTX - US30315R1077 - Common Stock

7.12 USD

0 (0%)

Last: 3/8/2023, 8:00:00 PM

7.12 USD

0 (0%)

After Hours: 3/8/2023, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FSTX Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: invoX Pharma

invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.

3 years ago - By: Benzinga - Mentions: ASLE GNLX QUOT VLON ...

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

3 years ago - By: Benzinga

Why F-Star Therapeutics Shares Are Moving Higher

3 years ago - By: Seeking Alpha

F-star Therapeutics stock surges as buyer Sino Biopharma gains CFIUS approval

3 years ago - By: F-star Therapeutics, Inc.

F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma

3 years ago - By: Seeking Alpha

CDTX, PTGX and TAST among premarket gainers (NASDAQ:FSTX)

3 years ago - By: Seeking Alpha

F-star Therapeutics stock surges on report sale to Sino Biopharma close to CFIUS Ok

3 years ago - By: Bloomberg

Sino Biopharm Wins CFIUS Approval for $161 Million F-Star Deal

3 years ago - By: Seeking Alpha

F-star Therapeutics jumps as it extends walk date with buyer to finalize CFIUS agreement

3 years ago - By: Seeking Alpha

F-star Therapeutics deal termination date with Sino Biopharma extended again

3 years ago - By: Seeking Alpha

F-star Therapeutics stock gains as buyer Sino Biopharma cancels Shanghai listing

3 years ago - By: F-star Therapeutics, Inc.

invoX Pharma and F-star Therapeutics issue Joint Statement

3 years ago - By: Seeking Alpha

FSTX stock rebounds as merger deadline extends again (NASDAQ:FSTX)

3 years ago - By: Seeking Alpha

FSTX stock sinks as CFIUS objects Sino-Biopharma deal (NASDAQ:FSTX)